0001382963-20-000075.txt : 20200410 0001382963-20-000075.hdr.sgml : 20200410 20200410171646 ACCESSION NUMBER: 0001382963-20-000075 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200410 DATE AS OF CHANGE: 20200410 EFFECTIVENESS DATE: 20200410 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Exalys Therapeutics, Inc. CENTRAL INDEX KEY: 0001808911 IRS NUMBER: 832253199 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-364777 FILM NUMBER: 20787210 BUSINESS ADDRESS: STREET 1: 12481 HIGH BLUFF DRIVE STREET 2: SUITE 150 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (949) 422-9676 MAIL ADDRESS: STREET 1: 12481 HIGH BLUFF DRIVE STREET 2: SUITE 150 CITY: SAN DIEGO STATE: CA ZIP: 92130 D 1 primary_doc.xml X0708 D LIVE 0001808911 Exalys Therapeutics, Inc. 12481 HIGH BLUFF DRIVE SUITE 150 SAN DIEGO CA CALIFORNIA 92130 (949) 422-9676 DELAWARE Derexa Therapeutics, Inc. None Corporation true 2018 Dennis Podlesak 12481 High Bluff Drive Suite 150 San Diego CA CALIFORNIA 92130 Executive Officer Director Lynne Rollins 12481 High Bluff Drive Suite 150 San Diego CA CALIFORNIA 92130 Executive Officer Michael Sanders 12481 High Bluff Drive Suite 150 San Diego CA CALIFORNIA 92130 Executive Officer Rick Orr 12481 High Bluff Drive Suite 150 San Diego CA CALIFORNIA 92130 Director Eckard Weber, M.D. 12481 High Bluff Drive Suite 150 San Diego CA CALIFORNIA 92130 Director Nicole Vitullo 12481 High Bluff Drive Suite 150 San Diego CA CALIFORNIA 92130 Director Brian Taylor Slingsby 12481 High Bluff Drive Suite 150 San Diego CA CALIFORNIA 92130 Director Takeshi Takahashi 12481 High Bluff Drive Suite 150 San Diego CA CALIFORNIA 92130 Director Pharmaceuticals Decline to Disclose 06b false 2020-04-03 true true true true false 0 25000000 4000186 20999814 false 2 0 0 0 false Exalys Therapeutics, Inc. /s/ Lynne Rollins Lynne Rollins Treasurer and Chief Financial Officer 2020-04-10